entinostat has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camphausen, K | 1 |
| Burgan, W | 1 |
| Cerra, M | 1 |
| Oswald, KA | 1 |
| Trepel, JB | 1 |
| Lee, MJ | 1 |
| Tofilon, PJ | 1 |
| Eyüpoglu, IY | 1 |
| Hahnen, E | 1 |
| Tränkle, C | 1 |
| Savaskan, NE | 1 |
| Siebzehnrübl, FA | 1 |
| Buslei, R | 1 |
| Lemke, D | 1 |
| Wick, W | 1 |
| Fahlbusch, R | 1 |
| Blümcke, I | 1 |
2 other studies available for entinostat and Glial Cell Tumors
| Article | Year |
|---|---|
Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.
Topics: Acetylation; Benzamides; Brain Neoplasms; Cell Cycle; Cell Survival; Enzyme Inhibitors; Glioma; Hist | 2004 |
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.
Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Brain; Cell Adhesion Molecules, Neu | 2006 |